164060 — Ilooda Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall Cap

Annual income statement for Ilooda Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	21,403	21,030	30,692	46,283	56,204
Cost of Revenue
Gross Profit	10,999	9,676	14,726	23,984	29,581
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	17,887	17,445	26,641	38,012	56,922
Operating Profit	3,516	3,585	4,051	8,271	-718
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,437	3,134	5,128	9,336	-6,042
Provision for Income Taxes
Net Income After Taxes	2,935	4,672	3,048	7,319	-5,144
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,935	4,672	3,369	7,879	-4,300
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	2,935	4,690	3,369	8,761	-4,300
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	230	588	216	388	-149
Dividends per Share